About Aditya Raghunath
Aditya Raghunath is a financial journalist who writes about business, public equities, and personal finance. His work has been published on several digital platforms in the U.S. and Canada, including The Motley Fool, Finscreener and Market Realist. With a post-graduate degree in finance, Aditya has close to 8 years of work experience in financial services and close to six years in producing financial content. Aditya’s area of expertise includes evaluating stocks in the tech and cannabis sectors. If you are considering investing in the stock market, he recommends reading The Intelligent Investor by Benjamin Graham before taking the plunge.
Recent Articles By Aditya Raghunath
Blink vs. Nuvve: Which Electric Vehicle Charging Stock is a Better Buy?
After an impressive rally in 2020, electric vehicle (EV) stocks have been trending lower, offering investors an opportunity to accumulate growth companies at cheaper prices. Today we’re going to take a look at two EV charging stocks, Blink Charging Co. (BLNK) and Nuvve Holding Corp. (NVVE), to see which is currently a better buy.
Curaleaf vs. Cresco Labs: Which Cannabis Stock is a Better Buy?
The recent wave of legalization in the U.S. makes cannabis stocks such as Curaleaf (CURLF) and Cresco Labs (CRLBF) top bets for 2021 and beyond. Both the companies are on track to post over a billion dollars in sales this year and their rising profit margins should allow them to deliver outsized gains for long-term investors. But which is the better investment right now?
Senseonics vs. Insulet: Which Diabetes Stock Is a Better Buy?
Senseonics Holdings (SENS) and Insulet (PODD) are two healthcare stocks that have the potential to outpace the broader markets over the long term. The two companies are part of a rapidly expanding market, allowing them to grow revenue and improve earnings in the process. But which between the two diabetes stocks should you buy today?
BlackBerry vs. MicroVision: Which Meme Stock in the Tech Sector is a Better Buy?
In the last month, retail traders on Reddit have orchestrated a series of short squeezes on meme stocks such as BlackBerry (BB) and MicroVision (MVIS). While both these stocks have gained momentum in recent sessions, which is a better buy between these two tech companies?
Nikola vs. Arrival: Which Electric Vehicle Stock Is a Better Buy?
Both Nikola (NKLA) and Arrival (ARVL) are companies that are yet to generate sales making it difficult to value these stocks. However, based on estimates, one is trading at a significantly lower valuation and also has more upside potential compared to Wall Street price target estimates.
Sundial vs. Greenlane: Which Cannabis Stock Is a Better Buy?
Sundial (SNDL) and Greenlane (GNLN) have burnt massive investor wealth in the last two years making them attractive contrarian bets. With the cannabis industry expected to grow at an exponential pace in the upcoming decade, should you buy marijuana producer Sundial or cannabis accessories company Greenlane? Read more to find out.
MicroVision vs. Ouster: Which Lidar Stock Is a Better Buy?
Lidar sensors are a core component for autonomous vehicles. This technology has been grabbing the limelight lately as more automakers and tech companies invest to develop self-driving cars. Further, the rapid advancements in the development of these vehicles will drive revenue for lidar companies higher in 2021 and beyond. Keeping this in mind, let’s see which between MicroVision (MVIS) and Ouster (OUST) is a better stock right now.
Senseonics vs. Tandem: Which Diabetes Stock is a Better Buy?
Given the rising number of people with diabetes, medical technology and devices that help diabetics live healthier lives are in great demand. Senseonics (SENS) and Tandem (TNDM) are two companies that focus on the treatment of diabetes. Which one of these stocks is a better buy now?
Sundial vs. Neptune Wellness: Which Cannabis Stock is a Better Buy?
Sundial Growers (SNDL) and Neptune Wellness (NEPT) are two small cap cannabis companies that have seen their share prices rally in the past month. Many believe that this positive momentum can continue, which is why today we’re going to analyze these two companies to see which is a better buy now.